A detailed history of Huntington National Bank transactions in Biogen Inc. stock. As of the latest transaction made, Huntington National Bank holds 2,308 shares of BIIB stock, worth $343,938. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,308
Previous 2,229 3.54%
Holding current value
$343,938
Previous $516,000 13.37%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$189.07 - $236.8 $14,936 - $18,707
79 Added 3.54%
2,308 $447,000
Q2 2024

Aug 08, 2024

BUY
$190.52 - $236.72 $9,907 - $12,309
52 Added 2.39%
2,229 $516,000
Q1 2024

May 03, 2024

SELL
$212.02 - $267.71 $26,714 - $33,731
-126 Reduced 5.47%
2,177 $469,000
Q4 2023

Feb 07, 2024

SELL
$222.59 - $267.94 $71,006 - $85,472
-319 Reduced 12.17%
2,303 $595,000
Q3 2023

Nov 08, 2023

SELL
$253.3 - $285.89 $1,519 - $1,715
-6 Reduced 0.23%
2,622 $673,000
Q2 2023

Aug 11, 2023

BUY
$275.25 - $318.06 $37,158 - $42,938
135 Added 5.42%
2,628 $748,000
Q1 2023

May 10, 2023

BUY
$256.56 - $292.34 $6,157 - $7,016
24 Added 0.97%
2,493 $693,000
Q4 2022

Feb 09, 2023

SELL
$252.44 - $306.72 $385,475 - $468,361
-1,527 Reduced 38.21%
2,469 $683,000
Q3 2022

Nov 07, 2022

SELL
$194.69 - $268.46 $30,566 - $42,148
-157 Reduced 3.78%
3,996 $1.07 Million
Q2 2022

Aug 09, 2022

BUY
$187.54 - $223.02 $286,936 - $341,220
1,530 Added 58.33%
4,153 $847,000
Q1 2022

May 10, 2022

BUY
$193.77 - $244.14 $968 - $1,220
5 Added 0.19%
2,623 $552,000
Q4 2021

Jan 21, 2022

SELL
$223.92 - $287.77 $36,051 - $46,330
-161 Reduced 5.79%
2,618 $628,000
Q3 2021

Oct 28, 2021

SELL
$282.99 - $369.05 $5,942 - $7,750
-21 Reduced 0.75%
2,779 $787,000
Q2 2021

Jul 30, 2021

BUY
$259.0 - $414.71 $341,621 - $547,002
1,319 Added 89.06%
2,800 $970,000
Q1 2021

Apr 12, 2021

BUY
$242.95 - $284.63 $14,819 - $17,362
61 Added 4.3%
1,481 $414,000
Q4 2020

Jan 11, 2021

SELL
$236.26 - $355.63 $1,417 - $2,133
-6 Reduced 0.42%
1,420 $348,000
Q3 2020

Oct 30, 2020

SELL
$264.77 - $305.71 $5,824 - $6,725
-22 Reduced 1.52%
1,426 $405,000
Q2 2020

Jul 30, 2020

SELL
$258.66 - $342.55 $75,528 - $100,024
-292 Reduced 16.78%
1,448 $388,000
Q1 2020

Apr 27, 2020

SELL
$268.85 - $341.04 $41,402 - $52,520
-154 Reduced 8.13%
1,740 $551,000
Q4 2019

Jan 17, 2020

BUY
$220.06 - $304.07 $35,869 - $49,563
163 Added 9.42%
1,894 $562,000
Q3 2019

Nov 01, 2019

SELL
$217.44 - $243.88 $88,715 - $99,503
-408 Reduced 19.07%
1,731 $403,000
Q2 2019

Jul 23, 2019

SELL
$219.29 - $241.72 $53,726 - $59,221
-245 Reduced 10.28%
2,139 $500,000
Q1 2019

Apr 09, 2019

SELL
$216.71 - $338.96 $17,336 - $27,116
-80 Reduced 3.25%
2,384 $563,000
Q4 2018

Jan 28, 2019

SELL
$278.5 - $352.75 $88,006 - $111,469
-316 Reduced 11.37%
2,464 $741,000
Q3 2018

Oct 18, 2018

BUY
$293.51 - $383.83 $110,359 - $144,320
376 Added 15.64%
2,780 $982,000
Q2 2018

Jul 19, 2018

SELL
$257.52 - $306.91 $19,571 - $23,325
-76 Reduced 3.06%
2,404 $698,000
Q1 2018

Apr 30, 2018

SELL
$260.13 - $367.91 $40,580 - $57,393
-156 Reduced 5.92%
2,480 $679,000
Q4 2017

Feb 02, 2018

SELL
$307.64 - $344.58 $19,381 - $21,708
-63 Reduced 2.33%
2,636 $840,000
Q3 2017

Oct 24, 2017

BUY
$281.15 - $329.69 $758,823 - $889,833
2,699
2,699 $845,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.5B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.